
### [MONDO:0017969](http://purl.obolibrary.org/obo/MONDO_0017969)
**Label:** 46,XY disorder of sex development of endocrine origin

**Subclasses:** [MONDO:0009384](http://purl.obolibrary.org/obo/MONDO_0009384) (leydig cell hypoplasia, type 1), [MONDO:0017971](http://purl.obolibrary.org/obo/MONDO_0017971) (46,XY disorder of sex development due to a cholesterol synthesis defect), [MONDO:0019597](http://purl.obolibrary.org/obo/MONDO_0019597) (46,XY disorder of sex development due to isolated 17,20-lyase deficiency), [MONDO:0017970](http://purl.obolibrary.org/obo/MONDO_0017970) (46,XY disorder of sex development due to impaired androgen production), [MONDO:0019155](http://purl.obolibrary.org/obo/MONDO_0019155) (leydig cell hypoplasia), [MONDO:0019595](http://purl.obolibrary.org/obo/MONDO_0019595) (46,XY disorder of sex development due to adrenal and testicular steroidogenesis defect), [MONDO:0008730](http://purl.obolibrary.org/obo/MONDO_0008730) (congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency), [MONDO:0019596](http://purl.obolibrary.org/obo/MONDO_0019596) (46,XY disorder of sex development due to testicular steroidogenesis defect), [MONDO:0019154](http://purl.obolibrary.org/obo/MONDO_0019154) (androgen insensitivity syndrome), [MONDO:0019594](http://purl.obolibrary.org/obo/MONDO_0019594) (46,XY disorder of sex development due to a testosterone synthesis defect), [MONDO:0008725](http://purl.obolibrary.org/obo/MONDO_0008725) (congenital lipoid adrenal hyperplasia due to STAR deficency), [MONDO:0020041](http://purl.obolibrary.org/obo/MONDO_0020041) (46,XY disorder of sex development due to a defect in testosterone metabolism by peripheral tissue), [MONDO:0018618](http://purl.obolibrary.org/obo/MONDO_0018618) (46,XY disorder of sexual development due to dihydrotestosterone backdoor pathway biosynthesis defect), 

**Corr. equiv. classes:** [OMIM:201710](http://purl.obolibrary.org/obo/OMIM_201710), [Orphanet:443090](http://www.orpha.net/ORDO/Orphanet_443090), [OMIM:300068](http://purl.obolibrary.org/obo/OMIM_300068), [Orphanet:98086](http://www.orpha.net/ORDO/Orphanet_98086), [OMIM:202110](http://purl.obolibrary.org/obo/OMIM_202110), [Orphanet:325357](http://www.orpha.net/ORDO/Orphanet_325357), [Orphanet:325511](http://www.orpha.net/ORDO/Orphanet_325511), [Orphanet:90796](http://www.orpha.net/ORDO/Orphanet_90796), [Orphanet:90786](http://www.orpha.net/ORDO/Orphanet_90786), [Orphanet:90787](http://www.orpha.net/ORDO/Orphanet_90787), [Orphanet:90790](http://www.orpha.net/ORDO/Orphanet_90790), [Orphanet:90793](http://www.orpha.net/ORDO/Orphanet_90793), [Orphanet:755](http://www.orpha.net/ORDO/Orphanet_755), [OMIM:238320](http://purl.obolibrary.org/obo/OMIM_238320), [Orphanet:754](http://www.orpha.net/ORDO/Orphanet_754), [Orphanet:90783](http://www.orpha.net/ORDO/Orphanet_90783), 

**Class expressions from DL-Learner:**

- [HP:0011969](http://purl.obolibrary.org/obo/HP_0011969) (Elevated circulating luteinizing hormone level) and (not ([HP:0040253](http://purl.obolibrary.org/obo/HP_0040253) (Increased size of the clitoris))) 62.50%
- [HP:0011969](http://purl.obolibrary.org/obo/HP_0011969) (Elevated circulating luteinizing hormone level) and (not ([HP:0040252](http://purl.obolibrary.org/obo/HP_0040252) (Abnormal size of the clitoris))) 62.50%
- [HP:0011969](http://purl.obolibrary.org/obo/HP_0011969) (Elevated circulating luteinizing hormone level) and (not ([HP:0008665](http://purl.obolibrary.org/obo/HP_0008665) (Clitoral hypertrophy))) 62.50%
- [HP:0011969](http://purl.obolibrary.org/obo/HP_0011969) (Elevated circulating luteinizing hormone level) and (not ([HP:0000056](http://purl.obolibrary.org/obo/HP_0000056) (Abnormality of the clitoris))) 62.50%
- [HP:0008730](http://purl.obolibrary.org/obo/HP_0008730) (Female external genitalia in individual with 46,XY karyotype) and [HP:0011969](http://purl.obolibrary.org/obo/HP_0011969) (Elevated circulating luteinizing hormone level) 57.22%
- [HP:0008232](http://purl.obolibrary.org/obo/HP_0008232) (Elevated circulating follicle stimulating hormone level) and [HP:0008730](http://purl.obolibrary.org/obo/HP_0008730) (Female external genitalia in individual with 46,XY karyotype) 57.22%
- [HP:0003241](http://purl.obolibrary.org/obo/HP_0003241) (External genital hypoplasia) and [HP:0011969](http://purl.obolibrary.org/obo/HP_0011969) (Elevated circulating luteinizing hormone level) 57.22%
- [HP:0003241](http://purl.obolibrary.org/obo/HP_0003241) (External genital hypoplasia) and [HP:0008232](http://purl.obolibrary.org/obo/HP_0008232) (Elevated circulating follicle stimulating hormone level) 57.22%
- [HP:0000140](http://purl.obolibrary.org/obo/HP_0000140) (Abnormality of the menstrual cycle) and [HP:0011969](http://purl.obolibrary.org/obo/HP_0011969) (Elevated circulating luteinizing hormone level) 57.22%
- [HP:0000140](http://purl.obolibrary.org/obo/HP_0000140) (Abnormality of the menstrual cycle) and [HP:0008232](http://purl.obolibrary.org/obo/HP_0008232) (Elevated circulating follicle stimulating hormone level) 57.22%
- [HP:0011969](http://purl.obolibrary.org/obo/HP_0011969) (Elevated circulating luteinizing hormone level) and (not ([HP:0100851](http://purl.obolibrary.org/obo/HP_0100851) (Abnormal emotion/affect behavior))) 57.22%
- [HP:0011969](http://purl.obolibrary.org/obo/HP_0011969) (Elevated circulating luteinizing hormone level) and (not ([HP:0100848](http://purl.obolibrary.org/obo/HP_0100848) (Neoplasm of the male external genitalia))) 57.22%
- [HP:0011969](http://purl.obolibrary.org/obo/HP_0011969) (Elevated circulating luteinizing hormone level) and (not ([HP:0100728](http://purl.obolibrary.org/obo/HP_0100728) (Germ cell neoplasia))) 57.22%
- [HP:0011969](http://purl.obolibrary.org/obo/HP_0011969) (Elevated circulating luteinizing hormone level) and (not ([HP:0100615](http://purl.obolibrary.org/obo/HP_0100615) (Ovarian neoplasm))) 57.22%
- [HP:0011969](http://purl.obolibrary.org/obo/HP_0011969) (Elevated circulating luteinizing hormone level) and (not ([HP:0100000](http://purl.obolibrary.org/obo/HP_0100000) (Early onset of sexual maturation))) 57.22%


